nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—peripheral nervous system neoplasm	0.34	1	CiPCiCtD
Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.257	1	CrCtD
Vinorelbine—Vindesine—Vincristine—peripheral nervous system neoplasm	0.0602	0.379	CrCrCtD
Vinorelbine—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.0602	0.379	CrCrCtD
Vinorelbine—ABCB1—peripheral nervous system neoplasm	0.0468	1	CbGaD
Vinorelbine—Voacamine—Vincristine—peripheral nervous system neoplasm	0.0384	0.242	CrCrCtD
Vinorelbine—TUBB4A—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB8—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB6—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB3—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB2A—Vincristine—peripheral nervous system neoplasm	0.0163	0.107	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.0136	0.0892	CbGbCtD
Vinorelbine—TUBB1—Vincristine—peripheral nervous system neoplasm	0.0136	0.0892	CbGbCtD
Vinorelbine—TUBB—Vincristine—peripheral nervous system neoplasm	0.0136	0.0892	CbGbCtD
Vinorelbine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00227	0.0149	CbGbCtD
Vinorelbine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.0149	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.0103	CbGbCtD
Vinorelbine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00136	0.00891	CbGbCtD
Vinorelbine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00127	0.00828	CbGbCtD
Vinorelbine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00097	0.00635	CbGbCtD
Vinorelbine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.000905	0.00592	CbGbCtD
Vinorelbine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.000889	0.00582	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.000606	0.00397	CbGbCtD
Vinorelbine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.000581	0.0038	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.00374	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.000533	0.00349	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000363	0.00238	CbGbCtD
Vinorelbine—Voacamine—ABCB1—peripheral nervous system neoplasm	0.00025	0.586	CrCbGaD
Vinorelbine—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000138	0.151	CbGdCrCtD
Vinorelbine—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000138	0.151	CbGdCrCtD
Vinorelbine—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000105	0.115	CbGdCrCtD
Vinorelbine—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	9.65e-05	0.106	CbGdCrCtD
Vinorelbine—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	9.65e-05	0.106	CbGdCrCtD
Vinorelbine—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	9.65e-05	0.106	CbGdCrCtD
Vinorelbine—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	9.65e-05	0.106	CbGdCrCtD
Vinorelbine—Vinblastine—ABCB1—peripheral nervous system neoplasm	8.94e-05	0.209	CrCbGaD
Vinorelbine—Vincristine—ABCB1—peripheral nervous system neoplasm	8.79e-05	0.205	CrCbGaD
Vinorelbine—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	7.31e-05	0.0801	CbGdCrCtD
Vinorelbine—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	7.31e-05	0.0801	CbGdCrCtD
Vinorelbine—Cough—Etoposide—peripheral nervous system neoplasm	1.86e-05	0.000433	CcSEcCtD
Vinorelbine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	1.86e-05	0.000433	CcSEcCtD
Vinorelbine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	1.86e-05	0.000433	CcSEcCtD
Vinorelbine—Headache—Topotecan—peripheral nervous system neoplasm	1.85e-05	0.000432	CcSEcCtD
Vinorelbine—Rash—Tretinoin—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Rash—Isotretinoin—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Fatigue—Vincristine—peripheral nervous system neoplasm	1.85e-05	0.000431	CcSEcCtD
Vinorelbine—Vomiting—Melphalan—peripheral nervous system neoplasm	1.84e-05	0.000429	CcSEcCtD
Vinorelbine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	1.84e-05	0.000429	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	1.84e-05	0.000429	CcSEcCtD
Vinorelbine—Headache—Isotretinoin—peripheral nervous system neoplasm	1.84e-05	0.000429	CcSEcCtD
Vinorelbine—Headache—Tretinoin—peripheral nervous system neoplasm	1.84e-05	0.000429	CcSEcCtD
Vinorelbine—Hypertension—Etoposide—peripheral nervous system neoplasm	1.84e-05	0.000428	CcSEcCtD
Vinorelbine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	1.83e-05	0.000427	CcSEcCtD
Vinorelbine—Constipation—Vincristine—peripheral nervous system neoplasm	1.83e-05	0.000427	CcSEcCtD
Vinorelbine—Pain—Vincristine—peripheral nervous system neoplasm	1.83e-05	0.000427	CcSEcCtD
Vinorelbine—Rash—Melphalan—peripheral nervous system neoplasm	1.83e-05	0.000426	CcSEcCtD
Vinorelbine—Dermatitis—Melphalan—peripheral nervous system neoplasm	1.83e-05	0.000425	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	1.82e-05	0.000424	CcSEcCtD
Vinorelbine—Chest pain—Etoposide—peripheral nervous system neoplasm	1.81e-05	0.000422	CcSEcCtD
Vinorelbine—Anorexia—Cisplatin—peripheral nervous system neoplasm	1.81e-05	0.000421	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	1.8e-05	0.000419	CcSEcCtD
Vinorelbine—Discomfort—Etoposide—peripheral nervous system neoplasm	1.79e-05	0.000417	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	1.78e-05	0.000416	CcSEcCtD
Vinorelbine—Hypotension—Cisplatin—peripheral nervous system neoplasm	1.77e-05	0.000413	CcSEcCtD
Vinorelbine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	1.77e-05	0.000412	CcSEcCtD
Vinorelbine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	1.77e-05	0.000412	CcSEcCtD
Vinorelbine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	1.76e-05	0.00041	CcSEcCtD
Vinorelbine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	1.76e-05	0.00041	CcSEcCtD
Vinorelbine—Nausea—Topotecan—peripheral nervous system neoplasm	1.76e-05	0.00041	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	1.75e-05	0.000409	CcSEcCtD
Vinorelbine—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	1.75e-05	0.000407	CcSEcCtD
Vinorelbine—Nausea—Tretinoin—peripheral nervous system neoplasm	1.74e-05	0.000406	CcSEcCtD
Vinorelbine—Nausea—Isotretinoin—peripheral nervous system neoplasm	1.74e-05	0.000406	CcSEcCtD
Vinorelbine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	1.74e-05	0.000405	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	1.73e-05	0.000403	CcSEcCtD
Vinorelbine—Infection—Etoposide—peripheral nervous system neoplasm	1.73e-05	0.000402	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	1.72e-05	0.000401	CcSEcCtD
Vinorelbine—Nausea—Melphalan—peripheral nervous system neoplasm	1.72e-05	0.000401	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	1.72e-05	0.0004	CcSEcCtD
Vinorelbine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	1.71e-05	0.000399	CcSEcCtD
Vinorelbine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	1.7e-05	0.000397	CcSEcCtD
Vinorelbine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	1.7e-05	0.000396	CcSEcCtD
Vinorelbine—Tachycardia—Etoposide—peripheral nervous system neoplasm	1.7e-05	0.000395	CcSEcCtD
Vinorelbine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	1.7e-05	0.000395	CcSEcCtD
Vinorelbine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	1.7e-05	0.000395	CcSEcCtD
Vinorelbine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	1.69e-05	0.000394	CcSEcCtD
Vinorelbine—Skin disorder—Etoposide—peripheral nervous system neoplasm	1.69e-05	0.000393	CcSEcCtD
Vinorelbine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	1.68e-05	0.000391	CcSEcCtD
Vinorelbine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	1.67e-05	0.000389	CcSEcCtD
Vinorelbine—Anorexia—Etoposide—peripheral nervous system neoplasm	1.66e-05	0.000386	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	1.65e-05	0.000385	CcSEcCtD
Vinorelbine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	1.65e-05	0.000384	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	1.64e-05	0.000383	CcSEcCtD
Vinorelbine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	1.64e-05	0.000382	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	1.64e-05	0.000381	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	1.63e-05	0.000379	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—peripheral nervous system neoplasm	1.62e-05	0.000378	CcSEcCtD
Vinorelbine—Pain—Cisplatin—peripheral nervous system neoplasm	1.62e-05	0.000378	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	1.62e-05	0.000377	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	1.6e-05	0.000373	CcSEcCtD
Vinorelbine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	1.6e-05	0.000372	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	1.58e-05	0.000369	CcSEcCtD
Vinorelbine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	1.58e-05	0.000368	CcSEcCtD
Vinorelbine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	1.57e-05	0.000367	CcSEcCtD
Vinorelbine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	1.56e-05	0.000364	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	1.56e-05	0.000364	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	1.55e-05	0.000362	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	1.55e-05	0.000361	CcSEcCtD
Vinorelbine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	1.55e-05	0.000361	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	1.54e-05	0.00036	CcSEcCtD
Vinorelbine—Asthenia—Vincristine—peripheral nervous system neoplasm	1.54e-05	0.000359	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	1.54e-05	0.000358	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000356	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—peripheral nervous system neoplasm	1.53e-05	0.000356	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	1.53e-05	0.000356	CcSEcCtD
Vinorelbine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	1.52e-05	0.000355	CcSEcCtD
Vinorelbine—Rash—Dactinomycin—peripheral nervous system neoplasm	1.51e-05	0.000353	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	1.51e-05	0.000352	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	1.51e-05	0.000351	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	1.5e-05	0.000349	CcSEcCtD
Vinorelbine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	1.5e-05	0.000349	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—peripheral nervous system neoplasm	1.5e-05	0.000349	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	1.5e-05	0.000349	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	1.49e-05	0.000347	CcSEcCtD
Vinorelbine—Pain—Etoposide—peripheral nervous system neoplasm	1.49e-05	0.000346	CcSEcCtD
Vinorelbine—Constipation—Etoposide—peripheral nervous system neoplasm	1.49e-05	0.000346	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	1.48e-05	0.000345	CcSEcCtD
Vinorelbine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	1.47e-05	0.000343	CcSEcCtD
Vinorelbine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	1.47e-05	0.000342	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	1.44e-05	0.000336	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	1.43e-05	0.000334	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	1.43e-05	0.000334	CcSEcCtD
Vinorelbine—Nausea—Dactinomycin—peripheral nervous system neoplasm	1.43e-05	0.000332	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	1.43e-05	0.000332	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	1.42e-05	0.000331	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	1.42e-05	0.000331	CcSEcCtD
Vinorelbine—Dizziness—Vincristine—peripheral nervous system neoplasm	1.42e-05	0.00033	CcSEcCtD
Vinorelbine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	1.42e-05	0.00033	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000329	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—peripheral nervous system neoplasm	1.41e-05	0.000329	CcSEcCtD
Vinorelbine—Rash—Alitretinoin—peripheral nervous system neoplasm	1.4e-05	0.000327	CcSEcCtD
Vinorelbine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	1.4e-05	0.000327	CcSEcCtD
Vinorelbine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	1.4e-05	0.000326	CcSEcCtD
Vinorelbine—Headache—Alitretinoin—peripheral nervous system neoplasm	1.39e-05	0.000325	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	1.39e-05	0.000323	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—peripheral nervous system neoplasm	1.38e-05	0.000322	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	1.38e-05	0.000321	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	1.37e-05	0.00032	CcSEcCtD
Vinorelbine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	1.37e-05	0.00032	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	1.36e-05	0.000318	CcSEcCtD
Vinorelbine—Vomiting—Vincristine—peripheral nervous system neoplasm	1.36e-05	0.000318	CcSEcCtD
Vinorelbine—Asthenia—Cisplatin—peripheral nervous system neoplasm	1.36e-05	0.000317	CcSEcCtD
Vinorelbine—Rash—Vincristine—peripheral nervous system neoplasm	1.35e-05	0.000315	CcSEcCtD
Vinorelbine—Dermatitis—Vincristine—peripheral nervous system neoplasm	1.35e-05	0.000315	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	1.35e-05	0.000314	CcSEcCtD
Vinorelbine—Headache—Vincristine—peripheral nervous system neoplasm	1.34e-05	0.000313	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	1.34e-05	0.000311	CcSEcCtD
Vinorelbine—Nausea—Alitretinoin—peripheral nervous system neoplasm	1.32e-05	0.000308	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	1.32e-05	0.000307	CcSEcCtD
Vinorelbine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	1.3e-05	0.000302	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	1.28e-05	0.000298	CcSEcCtD
Vinorelbine—Nausea—Vincristine—peripheral nervous system neoplasm	1.27e-05	0.000297	CcSEcCtD
Vinorelbine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	1.27e-05	0.000296	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—peripheral nervous system neoplasm	1.27e-05	0.000296	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	1.26e-05	0.000294	CcSEcCtD
Vinorelbine—Asthenia—Etoposide—peripheral nervous system neoplasm	1.25e-05	0.00029	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	1.25e-05	0.00029	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.00029	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.000288	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	1.24e-05	0.000288	CcSEcCtD
Vinorelbine—Pruritus—Etoposide—peripheral nervous system neoplasm	1.23e-05	0.000286	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	1.22e-05	0.000285	CcSEcCtD
Vinorelbine—Alopecia—Epirubicin—peripheral nervous system neoplasm	1.21e-05	0.000282	CcSEcCtD
Vinorelbine—Vomiting—Cisplatin—peripheral nervous system neoplasm	1.21e-05	0.000281	CcSEcCtD
Vinorelbine—Rash—Cisplatin—peripheral nervous system neoplasm	1.2e-05	0.000279	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	1.19e-05	0.000278	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000278	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	1.19e-05	0.000278	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	1.19e-05	0.000277	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—peripheral nervous system neoplasm	1.18e-05	0.000274	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	1.18e-05	0.000274	CcSEcCtD
Vinorelbine—Back pain—Epirubicin—peripheral nervous system neoplasm	1.15e-05	0.000269	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.000268	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—peripheral nervous system neoplasm	1.15e-05	0.000268	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	1.15e-05	0.000267	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	1.14e-05	0.000266	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	1.13e-05	0.000264	CcSEcCtD
Vinorelbine—Nausea—Cisplatin—peripheral nervous system neoplasm	1.13e-05	0.000262	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	1.12e-05	0.000261	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	1.11e-05	0.000258	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—peripheral nervous system neoplasm	1.1e-05	0.000257	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000257	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	1.1e-05	0.000257	CcSEcCtD
Vinorelbine—Anaemia—Epirubicin—peripheral nervous system neoplasm	1.1e-05	0.000257	CcSEcCtD
Vinorelbine—Rash—Etoposide—peripheral nervous system neoplasm	1.1e-05	0.000255	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—peripheral nervous system neoplasm	1.09e-05	0.000255	CcSEcCtD
Vinorelbine—Headache—Etoposide—peripheral nervous system neoplasm	1.09e-05	0.000254	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—peripheral nervous system neoplasm	1.08e-05	0.000251	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.00025	CcSEcCtD
Vinorelbine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	1.07e-05	0.000249	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—peripheral nervous system neoplasm	1.07e-05	0.000249	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—peripheral nervous system neoplasm	1.05e-05	0.000246	CcSEcCtD
Vinorelbine—Cough—Epirubicin—peripheral nervous system neoplasm	1.04e-05	0.000243	CcSEcCtD
Vinorelbine—Nausea—Etoposide—peripheral nervous system neoplasm	1.03e-05	0.00024	CcSEcCtD
Vinorelbine—Hypertension—Epirubicin—peripheral nervous system neoplasm	1.03e-05	0.00024	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	1.02e-05	0.000239	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	1.02e-05	0.000238	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—peripheral nervous system neoplasm	1.02e-05	0.000237	CcSEcCtD
Vinorelbine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	1.02e-05	0.000237	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—peripheral nervous system neoplasm	1.02e-05	0.000237	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	1.01e-05	0.000235	CcSEcCtD
Vinorelbine—Discomfort—Epirubicin—peripheral nervous system neoplasm	1e-05	0.000234	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.96e-06	0.000232	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	9.92e-06	0.000231	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	9.88e-06	0.00023	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.76e-06	0.000227	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.74e-06	0.000227	CcSEcCtD
Vinorelbine—Infection—Epirubicin—peripheral nervous system neoplasm	9.68e-06	0.000225	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—peripheral nervous system neoplasm	9.64e-06	0.000224	CcSEcCtD
Vinorelbine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.55e-06	0.000223	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	9.54e-06	0.000222	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.53e-06	0.000222	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	9.51e-06	0.000221	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.46e-06	0.00022	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.4e-06	0.000219	CcSEcCtD
Vinorelbine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.4e-06	0.000219	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	9.4e-06	0.000219	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.34e-06	0.000218	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	9.29e-06	0.000216	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.28e-06	0.000216	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.1e-06	0.000212	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.01e-06	0.00021	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—peripheral nervous system neoplasm	8.95e-06	0.000209	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.87e-06	0.000207	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.84e-06	0.000206	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	8.82e-06	0.000206	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.8e-06	0.000205	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.75e-06	0.000204	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	8.75e-06	0.000204	CcSEcCtD
Vinorelbine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.68e-06	0.000202	CcSEcCtD
Vinorelbine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	8.59e-06	0.0002	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.47e-06	0.000197	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	8.42e-06	0.000196	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.41e-06	0.000196	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—peripheral nervous system neoplasm	8.4e-06	0.000196	CcSEcCtD
Vinorelbine—Pain—Epirubicin—peripheral nervous system neoplasm	8.33e-06	0.000194	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—peripheral nervous system neoplasm	8.33e-06	0.000194	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.21e-06	0.000191	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.09e-06	0.000189	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.03e-06	0.000187	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.03e-06	0.000187	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.96e-06	0.000186	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	7.83e-06	0.000183	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.78e-06	0.000181	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	7.77e-06	0.000181	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.74e-06	0.00018	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—peripheral nervous system neoplasm	7.71e-06	0.00018	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—peripheral nervous system neoplasm	7.71e-06	0.00018	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.7e-06	0.000179	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.7e-06	0.000179	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.43e-06	0.000173	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.37e-06	0.000172	CcSEcCtD
Vinorelbine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.18e-06	0.000167	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.16e-06	0.000167	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.12e-06	0.000166	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.12e-06	0.000166	CcSEcCtD
Vinorelbine—Asthenia—Epirubicin—peripheral nervous system neoplasm	6.99e-06	0.000163	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.89e-06	0.000161	CcSEcCtD
Vinorelbine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.66e-06	0.000155	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.64e-06	0.000155	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.47e-06	0.000151	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.44e-06	0.00015	CcSEcCtD
Vinorelbine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.38e-06	0.000149	CcSEcCtD
Vinorelbine—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.19e-06	0.000144	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.17e-06	0.000144	CcSEcCtD
Vinorelbine—Rash—Epirubicin—peripheral nervous system neoplasm	6.14e-06	0.000143	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.14e-06	0.000143	CcSEcCtD
Vinorelbine—Headache—Epirubicin—peripheral nervous system neoplasm	6.1e-06	0.000142	CcSEcCtD
Vinorelbine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.96e-06	0.000139	CcSEcCtD
Vinorelbine—Nausea—Epirubicin—peripheral nervous system neoplasm	5.79e-06	0.000135	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.73e-06	0.000133	CcSEcCtD
Vinorelbine—Rash—Doxorubicin—peripheral nervous system neoplasm	5.68e-06	0.000132	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.68e-06	0.000132	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—peripheral nervous system neoplasm	5.65e-06	0.000132	CcSEcCtD
Vinorelbine—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.35e-06	0.000125	CcSEcCtD
